Company continually strives to comply to the current Good Manufacturing Practices (cGMP) guidelines.
Our Unit-1 at Hyderabad was successfully inspected by the US FDA during September 2000, in April 2004, in February 2008, in July, 2011 and in June, 2014. Our Unit-2 at Visakhapatnam was successfully inspected by the US FDA during November 2006, April 2009, July 2012, June 2014 and February 2016. Our facilities have also been inspected by other international regulatory agencies.
Divis also undertakes FTE/Contract Research on process development for discovering new compounds for leading MNCs across the world and partners with them for the supply of APIs.
The company is global in its outlook and benchmarks its quality standards to the best in the world and constantly reviews and updates the same from time to time.